Publications To Date

    nCOUNTER PUBLICATIONS

    Filter Publications

    PAGE 4 OF 9 | DISPLAYING 46 - 60 OF 134 RESULTS

    Ayers, et al. IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade , Epub, Journal of Clinical Investigation (JCI), Jun 26, 2017

    Ling B. et al., A novel immunotherapy targeting MMP-14 limits hypoxia, immune suppression and metastasis in triple-negative breast cancer models, 10.18632/oncotarget.17702 , Oncotarget, May 09, 2017

    Gómez-Miragaya J, et al. Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population, Volumes 1 - 8 (2013 - 2017), Stem Cell Reports, May 09, 2017

    Jochems C, et al. ADCC employing an NK cell line (haNK) expressing the high affinity CD16 allele with avelumab, an anti-PD-L1 antibody, DOI: 10.1002/ijc.30767, IJC, May 06, 2017

    Pollack S.M. et al., T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas, 10.1002/cncr.30726, Cancer, May 02, 2017

    Thieblemont C, et al. Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone., 2017726984. , J. Clin. Oncol., Apr 20, 2017

    Daley D. et al., Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance, [Epub ahead of print]., Nat. Med., Apr 10, 2017

    Gao J. et al., VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer, [Epub ahead of print]., Nat. Med., Mar 27, 2017

    Siska P.J. et al., Deep Exploration of the Immune Infiltrate and Outcome Prediction in Testicular Cancer by Quantitative Multiplexed Immunohistochemistry and Gene Expression Profiling., [Epub ahead of print]., OncoImmunol., Mar 20, 2017

    Stevenson M.L. et al., Expression of Programmed Cell Death Ligand in Cutaneous Squamous Cell Carcinoma and Treatment of Locally Advanced Disease With Pembrolizumab., [Epub ahead of print]., JAMA Dermatol., Mar 04, 2017

    Zamarin D et al., Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity, [Epub ahead of print]., Nat. Commun., Feb 13, 2017

    Irawan C. et al., Expression of Biomarkers CXCR4, IL11-RA, TFF1, MLF1P in Advanced Breast Cancer Patients with Bone Metastatic: a Diagnostic Study, [Epub ahead of print]., Acta Medica Indonesian, Feb 01, 2017

    Keane C. et al., The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma, [Epub ahead of print]., Clin. Can. Res., Jan 24, 2017

    Rafiq S. et al., Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen., [Epub ahead of print]., Leukemia, Jan 03, 2017

    Bresler S.C. et al., Gene expression profiling of anti-CTLA4-treated metastatic melanoma in patients with treatment-induced autoimmunity, [Epub ahead of print]., Lab Invest., Dec 05, 2016